Michael Tayao

ORCID: 0000-0001-5224-0784
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic and Hepatic Oncology Research
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Receptor Mechanisms and Signaling
  • Cancer Cells and Metastasis
  • Retinal Development and Disorders
  • Advanced Fluorescence Microscopy Techniques
  • Caveolin-1 and cellular processes
  • Cellular Mechanics and Interactions
  • Cancer Research and Treatments
  • 3D Printing in Biomedical Research
  • Cancer, Stress, Anesthesia, and Immune Response
  • Neuroendocrine Tumor Research Advances
  • Microbial metabolism and enzyme function
  • Renal cell carcinoma treatment
  • Gastrointestinal disorders and treatments
  • Peptidase Inhibition and Analysis
  • Neuropeptides and Animal Physiology
  • Phagocytosis and Immune Regulation

The Kinghorn Cancer Centre
2021-2025

Garvan Institute of Medical Research
2019-2025

UNSW Sydney
2021-2023

St Vincent's Clinic
2021-2023

Joyson Safety Systems (Japan)
2016

Gallagher (United States)
2016

St. Leonards Hospital
2016

University of Technology Sydney
2016

Keogh Institute for Medical Research
2016

Jessica L. Chitty Michelle Yam Lara Perryman Amelia L. Parker Joanna N. Skhinas and 95 more Yordanos F. Setargew Ellie T. Y. Mok Emmi Tran Rhiannon D. Grant Sharissa L. Latham Brooke A. Pereira Shona Ritchie Kendelle J. Murphy Michael Trpceski Alison D. Findlay Pauline Mélénec Elysse C. Filipe Audrey Nadalini Sipiththa Velayuthar Gretel Major Kaitlin Wyllie Michael Papanicolaou Shivanjali Ratnaseelan Phoebe A. Phillips George Sharbeen Janet Youkhana Alice G. Russo Antonia Blackwell Jordan F. Hastings Morghan C. Lucas Cecilia R. Chambers Daniel A. Reed Janett Stoehr Claire Vennin Ruth Pidsley Anaiis Zaratzian Andrew M. Da Silva Michael Tayao Brett Charlton David Herrmann Max Nobis Susan J. Clark Andrew V. Biankin Amber L. Johns David R. Croucher Adnan Nagrial Anthony J. Gill Sean M. Grimmond Lorraine A. Chantrill Angela Chou Tanya Dwarte Xanthe L. Metcalf Gloria Jeong Lara Kenyon Nicola Waddell John V. Pearson Ann-Marie Patch Kátia Nones Felicity Newell Pamela Mukhopadhyay Venkateswar Addala Stephen H. Kazakoff Oliver Holmes Conrad Leonard Scott Wood Oliver Hofmann Jaswinder S. Samra Nick Pavlakis Jennifer Arena Hilda High Ray Asghari Neil D. Merrett Amitabha Das Peter H. Cosman Kasim Ismail Alina Stoita David B. Williams Allan Spigellman Duncan McLeo Judy Kirk James G. Kench Peter Grimison Charbel Sandroussi Annabel Goodwin R. Scott Mead Katherine L. Tucker Lesley Andrews Michael Texler Cindy Forrest Mo Ballal David Fletcher Maria Beilin Kynan Feeney Krishna Epari Sanjay Mukhedkar Nikolajs Zeps Nan Q. Nguyen Andrew Ruszkiewicz Chris Worthley John Chen

Abstract The lysyl oxidase family represents a promising target in stromal targeting of solid tumors due to the importance this crosslinking and stabilizing fibrillar collagens its known role tumor desmoplasia. Using small-molecule drug-design approaches, we generated validated PXS-5505, first-in-class highly selective potent pan-lysyl inhibitor. We demonstrate vitro vivo that inhibition decreases chemotherapy-induced pancreatic desmoplasia stiffness, reduces cancer cell invasion metastasis,...

10.1038/s43018-023-00614-y article EN cc-by Nature Cancer 2023-08-28

Abstract In recent decades, the role of tumor biomechanics on cancer cell behavior at primary site has been increasingly appreciated. However, effect latter stages metastatic cascade, such as seeding secondary sites and outgrowth remains underappreciated. This work sought to address this in context triple negative breast (TNBC), a type known aggressively disseminate all disease progression. Using mechanically tuneable model systems, mimicking range stiffness's typically found within tumors,...

10.1002/advs.202307963 article EN cc-by Advanced Science 2024-04-11

BRCA1-associated protein 1 (BAP1) is a deubiquitinating enzyme that functions as tumor suppressor gene. Double hit BAP1 inactivation has been reported in range of types, including intrahepatic cholangiocarcinoma (ICC), sometimes association with germline mutation.We performed immunohistochemistry for on well-characterized cohort 211 ICC patients undergoing surgical resection curative intent at 3 institutions based different countries. The median age diagnosis was 65 years (range, 36.5-86)...

10.1097/md.0000000000002491 article EN cc-by-nc Medicine 2016-01-01

Pancreatic cancer (PC) is a highly metastatic malignancy. More than 80% of patients with PC present advanced-stage disease, preventing potentially curative surgery. The neuropeptide Y (NPY) system, best known for its role in controlling energy homeostasis, has also been shown to promote tumorigenesis range types, but yet be explored. We show that expression NPY and NPY1R are up-regulated mouse models human PC. Moreover, using the genetically engineered, autochthonous KP R172H C model PC, we...

10.1126/sciadv.adq4416 article EN cc-by-nc Science Advances 2025-03-12

Background Pancreatic cancer is both common and highly lethal therefore new biomarkers or potential targets for treatment are needed. Loss of BRCA associated protein-1 (BAP1) expression has been found in up to a quarter intrahepatic cholangiocarcinomas. Given the close anatomical relationship between cholangiocarcinoma pancreatic ductal adenocarcinoma, we sought investigate frequency loss BAP1 adenocarcinoma. Methods The records department Anatomical Pathology Royal North Shore Hospital,...

10.1371/journal.pone.0150338 article EN cc-by PLoS ONE 2016-03-16

Abstract Background The use of in vitro cell cultures is a powerful tool for obtaining key insights into the behaviour and response cells to interventions normal disease situations. Unlike vivo settings, experiments allow fine‐tuned control range microenvironmental elements independently within an isolated setting. recent expansion three‐dimensional (3D) assays has created number representative tools study more physiologically 3D relevant microenvironment. Complex models that can...

10.1002/cnr2.1209 article EN cc-by-nc Cancer Reports 2019-08-01

<p>Assessing drug response within live native tissue provides increased fidelity with regards to optimizing efficacy while minimizing off-target effects. Here, using longitudinal intravital imaging of a Rac1-Forster resonance energy transfer (FRET) biosensor mouse coupled in vivo photoswitching track intratumoral movement, we help guide treatment scheduling breast cancer setting impair metastatic progression. We uncover altered Rac1 activity at the center versus invasive border tumors...

10.32920/21985085 preprint EN cc-by 2023-01-31

<p>Assessing drug response within live native tissue provides increased fidelity with regards to optimizing efficacy while minimizing off-target effects. Here, using longitudinal intravital imaging of a Rac1-Forster resonance energy transfer (FRET) biosensor mouse coupled in vivo photoswitching track intratumoral movement, we help guide treatment scheduling breast cancer setting impair metastatic progression. We uncover altered Rac1 activity at the center versus invasive border tumors...

10.32920/21985085.v1 preprint EN cc-by 2023-01-31
Coming Soon ...